Table 1.
Demographic and biochemical parameters of the studied population.
| Items | Patients (n = 268) |
|---|---|
| Age, years | 48.7 ± 10.9 |
| Gender, male, n (%) | 149 (55.6%) |
| Primary disease | |
| Chronic glomerulonephritis, n (%) | 106 (37.1%) |
| Hypertensive nephropathy, n (%) | 31 (11.6%) |
| Diabetic nephropathy, n (%) | 45 (16.8%) |
| Chronic interstitial nephritis, n (%) | 22 (8.2%) |
| Polycystic kidney disease, n (%) | 15 (5.6%) |
| Unknown, n (%) | 49 (18.3%) |
| Dialysis duration, months | 45.9 ± 32.5 |
| Smoking, n (%) | 71 (26.5%) |
| Diabetes, n (%) | 49 (18.3%) |
| NLR | 3.36 ± 1.65 |
| LVMI, g/height2.7 | 53.3 ± 10.5 |
| LVMI > 50 g/height2.7, n (%) | 140 (50.2%) |
| PP, mmHg | 67.6 ± 18.1 |
| PP > 65 mmHg, n (%) | 105 (39.2%) |
| cfPWV (mm/s) | 14.7 ± 5.9 |
| IMT (mm) | 1.15 ± 0.16 |
| Plaque, n (%) | 119 (44.4%) |
| KT/V | 1.36 ± 0.03 |
| Hb, g/L | 114.9 ± 12.7 |
| Alb, g/L | 36.3 ± 3.5 |
| ALT, U/L | 14.9 ± 5.8 |
| AST, U/L | 14.3 ± 6.2 |
| TG, mmol/L | 1.82 ± 1.17 |
| Tch, mmol/L | 4.24 ± 0.86 |
| LDL-C, mmol/L | 2.24 ± 0.63 |
| hsCRP, mmol/L | 4.85 ± 3.40 |
| Cr, mol/L | 913.6 ± 167.9 |
| BUN, mmol/L | 24.8 ± 6.0 |
| Ca, mmol/L | 2.29 ± 0.33 |
| P, mmol/L | 1.93 ± 0.60 |
| iPTH, pg/ml | 270.6 ± 125.8 |
| RASI, n (%) | 203 (75.7%) |
| CCB, n (%) | 209 (78.0%) |
| β-Blocker, n (%) | 79 (29.1%) |
Values are means ± SD, unless specified otherwise.
NLR: neutrophil to lymphocyte ratio; LVMI: left ventricular mass index; PP: pulse pressure; cfPWV: carotid–femoral pulse wave velocity; IMT: intima-media thickness; Hb: hemoglobin; Alb: albumin; ALT: alanine transaminase; AST: aspartate aminotransferase; TG: triglyceride; Tch: total cholesterol; LDL-C: low density lipoprotein-cholesterol; hsCRP: high sensitivity C reactive protein; Cr: creatinine; BUN: blood urea nitrogen; Ca: calcium; P: phosphorus; iPTH: intact parathyroid hormone; RASI: renin angiotensin system inhibitor; CCB: calcium channel blocker; β-blocker: β-receptor blocker.